Abstract |
Chickens inoculated with herpesvirus of turkeys or with apathogenic or attenuated vaccine strains of Marek's disease virus (MDV) developed a T-cell-mediated immune response to Marek's disease (MD) tumor cells. This immune response was detected in a 4-hour 51Cr-release assay in which effector cells obtained from spleens of vaccinated chickens were reacted with 51Cr-labeled target cells of an MD lymphoblastoid cell line (MSB-1). The cytotoxic effector cells generated by the vaccine viruses had characteristics similar to those noted previously for anti-MSB-1 effector cells generated by MDV. The immune response was specific to MSB-1 cells, because another target cell line (TLT) antigenically unrelated to MSB-1 cells was not lysed by the effector cells nor did the unrelated target cells inhibit the cytotoxicity of effector cells against MSB-1 target in a cold-target inhibition assay. Because MSB-1 cells contain MD tumor-associated surface antigen, we postulated that the immune response detected in the vaccinated chickens may be directed against this antigen and that the antitumor antigen immunity may play a role in the mechanism of vaccine protection against lymphoma development by pathogenic MDV.
|
Authors | J M Sharma, R L Witter, B D Coulson |
Journal | Journal of the National Cancer Institute
(J Natl Cancer Inst)
Vol. 61
Issue 5
Pg. 1273-80
(Nov 1978)
ISSN: 0027-8874 [Print] United States |
PMID | 213610
(Publication Type: Journal Article)
|
Chemical References |
- Antigens, Neoplasm
- Antigens, Surface
- Antigens, Viral
- Viral Vaccines
- Neuraminidase
|
Topics |
- Animals
- Antigens, Neoplasm
(administration & dosage)
- Antigens, Surface
- Antigens, Viral
(administration & dosage)
- Chickens
- Cytotoxicity, Immunologic
- Herpesvirus 2, Gallid
(immunology)
- Hot Temperature
- Immunity, Cellular
- In Vitro Techniques
- Marek Disease
(immunology)
- Neuraminidase
(pharmacology)
- T-Lymphocytes
(immunology)
- Viral Vaccines
(pharmacology)
|